What are the side effects of ciprofloxacin?

Ciprofloxacin Side Effects

Ciprofloxacin causes gastrointestinal side effects most commonly (nausea, vomiting, diarrhea in 2-8% of patients), but carries serious risks including tendon rupture, QT prolongation, central nervous system effects, and peripheral neuropathy that require immediate discontinuation. 1

Common Side Effects (Occur in 1-10% of patients)

Gastrointestinal Effects (Most Frequent)

• Nausea, vomiting, diarrhea, abdominal pain - occur in 2-8% of patients 2, 3
• Dyspepsia
• These are typically mild to moderate and the most common reason patients cite for stopping the medication 4

Central Nervous System Effects

• Headache, dizziness - occur in 1-4% of patients 2, 3
• Insomnia, nervousness
• Confusion, tremors 1
• Recent case reports document ciprofloxacin-induced unilateral tremor and weakness mimicking stroke 5

Other Common Effects

• Vaginal yeast infections 1
• Transient elevation of liver enzymes 1, 3
• Skin rash or pruritus (approximately 1%) 3

Serious Side Effects Requiring Immediate Discontinuation

Tendon Damage (BLACK BOX WARNING)

Stop ciprofloxacin immediately if tendon pain, swelling, or inflammation occurs. 1

• Tendinitis and tendon rupture - most commonly affects the Achilles tendon 1
• Can occur during treatment or up to several months after completion 1
• Higher risk in patients:
  • Age >60 years 6
  • Taking corticosteroids 1
  • With kidney, heart, or lung transplants 1
  • With previous tendon disorders 1

Peripheral Neuropathy

Discontinue immediately if symptoms of nerve damage develop - this can become permanent. 1

• Pain, burning, tingling, numbness, or weakness in arms, hands, legs, or feet 1
• Can occur rapidly after starting treatment 1

Cardiac Effects

QT interval prolongation leading to potentially fatal arrhythmias 1

• Higher risk in:
  • Elderly patients 6
  • Those with family history of QT prolongation 1
  • Patients with low potassium (hypokalemia) 1
  • Those taking antiarrhythmics, tricyclic antidepressants, macrolides, or antipsychotics 7
• Moxifloxacin carries twice the arrhythmia risk compared to ciprofloxacin 6

Central Nervous System Toxicity

Can occur after the first dose - discontinue if these develop: 1

• Seizures (especially in patients with CNS disorders or epilepsy) 1
• Hallucinations, paranoia
• Suicidal thoughts or acts 1
• Severe confusion, depression 1
• Agitation, anxiety, insomnia 6

Severe Allergic Reactions

Stop immediately and seek emergency care: 1

• Anaphylaxis (can occur after first dose) 1
• Stevens-Johnson syndrome or toxic epidermal necrolysis 1
• Hives, throat tightness, difficulty breathing or swallowing 1

Hepatotoxicity

Stop if jaundice or dark urine develops: 1

• Hepatitis, acute hepatic necrosis 1
• Recent case report of hepatocellular injury in elderly patient with polypharmacy 8
• Transaminase elevations usually mild and reversible 3

Clostridioides difficile Colitis

• Watery or bloody diarrhea, abdominal cramps, fever 1
• Can occur 2+ months after completing antibiotics 1
• Notably, pseudomembranous colitis was NOT observed in long-term therapy studies 9

Other Serious Effects

• Hypoglycemia - especially when combined with glyburide 1
• Photosensitivity - severe sunburn, blisters, skin swelling 1
• Blood disorders (rare): thrombocytopenia, leukopenia, anemia 1

Special Population Considerations

Pediatric Patients (<18 years)

Musculoskeletal adverse events occur more frequently: 10, 11

• 9.3% in ciprofloxacin-treated children vs 6.0% in controls 11
• Most events are moderate intensity and transient 11
• Joint problems warrant immediate provider notification 1
• Sleep disturbance, gastrointestinal disturbance, arthritis, peripheral neuropathy 10

Geriatric Patients (≥65 years)

Higher risk for multiple serious adverse events: 6

• Tendinitis and tendon rupture 6
• QT prolongation, aortic aneurysm, aortic dissection 6
• CNS effects (agitation, confusion, dizziness, weakness) are potentiated 6
• Levofloxacin has higher dizziness risk than ciprofloxacin 6

Pregnant Women

• Teratogenic risk appears low but is not fully established 4
• Recommended only when severity of infection outweighs risks 4

Breastfeeding

• Low concentrations in breast milk (peak 3.79 mg/L at 2 hours, very low by 12-24 hours) 12
• Considered low risk 12
• Monitor infant for diarrhea or candidiasis 12

Critical Drug Interactions

Absorption Reduced By (separate dosing by 2 hours before or 4 hours after ciprofloxacin):

• Antacids, calcium, iron, magnesium 7
• Dairy products or mineral-fortified drinks 7
• Phosphate binders 7

Increased Toxicity Risk:

• Theophylline - increased levels leading to seizures; monitor levels closely 7, 1
• Warfarin - enhanced anticoagulant effect 7
• Tizanidine - CONTRAINDICATED (severe hypotension/sedation) 7
• Clozapine, duloxetine, ropinirole - increased drug levels 7
• Methotrexate - increased toxicity risk 7

Overall Safety Profile

Long-term therapy data (up to 130 days) shows ciprofloxacin is generally well-tolerated: 9

• Most adverse events occur early in therapy with little increase over time 9
• Discontinuation rate due to side effects: 1.5% 2
• Serious adverse events: 0.6% of patients 2
• 94% of reactions are mild to moderate 2

The key to safe ciprofloxacin use is immediate recognition and discontinuation when serious adverse effects develop, particularly tendon pain, neuropathy symptoms, CNS effects, or cardiac rhythm changes.